Biofil Chemicals and Pharmaceuticals Ltd

Biofil Chemicals and Pharmaceuticals Limited will hold a meeting of its Board of Directors on November 14, 2026, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026, along with the limited review report thereon. The company's BSE scrip code is 524396 and NSE symbol is BIOFILCHEM, with ISIN INE829A01014. Trading window for company securities will open 48 hours after the declaration of the financial results for designated persons, immediate relatives, and connected persons, as per SEBI regulations.

Biofil Chemicals and Pharmaceuticals Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming the dematerialization of securities and related actions by Ankit Consultancy Private Limited, the company's registrar and share transfer agent.

Biofil Chemicals and Pharmaceuticals Limited announced that members approved the continuation of Ashok Kumar Ramawat's directorship as a Non-Executive Independent Director, despite him attaining the age of 75 years, at the company's 41st Annual General Meeting held on September 23, 2026. Mr. Ramawat, who holds DIN: 08818263, has completed a Bachelor's degree in Science and possesses 46 years of experience in the pharmaceuticals industry, and his directorship will continue until September 27, 2027, when he reaches the age of 75.

Biofil Chemicals and Pharmaceuticals Limited will close its trading window for designated persons, their immediate relatives, and connected persons starting October 1, 2026, to consider unaudited financial results for the quarter ended September 30, 2026, in compliance with SEBI regulations. The trading window will reopen 48 hours after the results are declared to the stock exchanges, and a board meeting to consider the results will be scheduled at a later date.

Biofil Chemicals and Pharmaceuticals Limited announced the continuation of Ashok Kumar Ramawat's directorship as a Non-Executive Independent Director, despite him attaining the age of 75 years. Ramawat was originally appointed on August 25, 2020, and his continued tenure is subject to shareholder approval via a special resolution at the company's 41st Annual General Meeting, in compliance with Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Biofil Chemicals and Pharmaceuticals Limited will hold a meeting of its Board of Directors on August 11, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report thereon, according to a regulatory filing. The company’s BSE scrip code is 524396 and NSE symbol is BIOFILCHEM, with ISIN INE829A01014. A trading window for designated persons, immediate relatives, and connected persons will open 48 hours after the declaration of the financial results.

Net profit of Biofil Chemicals & Pharmaceuticals rose 5.00% to Rs 0.21 crore in the quarter ended March 2026 as against Rs 0.20 crore during the previous quarter ended March 2025. Sales declined 9.34% to Rs 7.57 crore in the quarter ended March 2026 as against Rs 8.35 crore during the previous quarter ended March 2025. For the full year,net profit rose 398.21% to Rs 2.79 crore in the year ended March 2026 as against Rs 0.56 crore during the previous year ended March 2025. Sales declined 14.97% to Rs 28.40 crore in the year ended March 2026 as against Rs 33.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales7.578.35 -9 28.4033.40 -15 OPM %5.681.32 -2.322.54 - PBDT0.540.34 59 3.731.12 233 PBT0.470.26 81 3.460.74 368 NP0.210.20 5 2.790.56 398 Powered by Capital Market - Live

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live

Indo US Bio-Tech Ltd, United Foodbrands Ltd, Veer Global Infraconstruction Ltd and Mahalaxmi Fabric Mills Ltd are among the other gainers in the BSE's 'B' group today, 02 February 2026.Biofil Chemicals & Pharmaceuticals Ltd surged 17.88% to Rs 40.81 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 51521 shares were traded on the counter so far as against the average daily volumes of 16624 shares in the past one month. Indo US Bio-Tech Ltd spiked 13.24% to Rs 135.95. The stock was the second biggest gainer in 'B' group. On the BSE, 6910 shares were traded on the counter so far as against the average daily volumes of 5797 shares in the past one month. United Foodbrands Ltd soared 13.00% to Rs 245.1. The stock was the third biggest gainer in 'B' group. On the BSE, 1.89 lakh shares were traded on the counter so far as against the average daily volumes of 5029 shares in the past one month. Veer Global Infraconstruction Ltd advanced 12.15% to Rs 107.88. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1 shares were traded on the counter so far as against the average daily volumes of 1192 shares in the past one month. Mahalaxmi Fabric Mills Ltd jumped 11.01% to Rs 25.2. The stock was the fifth biggest gainer in 'B' group. On the BSE, 203 shares were traded on the counter so far as against the average daily volumes of 769 shares in the past one month. Powered by Capital Market - Live